Acute ischaemic stroke is a major public health priority and will become increasingly
relevant to neurologists of the future. The cornerstone of effective stroke care continues to be …

Stroke is a major contributor to death and disability worldwide. Prior to modern therapy, post-
stroke mortality was approximately 10% in the acute period, with nearly one-half of the …

A growing body of clinical evidence shows that vascular leakage leads to pulmonary edema
in coronavirus disease 2019 (COVID-19) patients. Coronaviruses including severe acute …

Episodic and recurrent local cutaneous or mucosal swelling are key features of
angioedema. The vasoactive agents histamine and bradykinin are highly implicated as …

The most effective medical treatment for acute ischaemic stroke (AIS) is to offer intravenous
thrombolysis during the ultra-early period of time after the onset. Even based on the …

The plasma contact system contributes to thrombosis in experimental models. Even though
our standard blood coagulation tests are prolonged when plasma lacks contact factors, this …

The likelihood of disability-free recovery after acute ischemic stroke is significantly improved
by reperfusion either by intravenous thrombolytic drug treatment or with endovascular …

Background and Purpose—Orolingual angioedema (OLAE) is a life-threatening
complication of intravenous thrombolysis. Our objective was to compare outcomes of …

Hereditary angioedema (HAE) was first described by Dinkelacker 1 and Quincke 2 in 1882
and a few years later by Osler 3 as recurrent angioedema with a positive family history. In …

Angioedema is characterized by localized deep dermal, subcutaneous, and/or mucosal
edema resulting from increased vasodilatation and vascular permeability. Nonsteroidal …